AstraZeneca/Daiichi Sankyo’s Enhertu To Get Lung Cancer Label For EU

The European Medicines Agency has recommended new uses for 11 approved medicines, including an antibody drug conjugate for treating advanced non-small cell lung cancer.

Medicine and health care concept, Professor Doctor presenting report of diagnosis and recommend something a method with patient treatment, after results about the problem illness of patient.
There Are Limited Approved Therapies For NSCLC Patients With HER2 Alterations • Source: Shutterstock

More from Europe

More from Geography